Evidence map›Paper›PMID 42681020›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Methods to Study CCT Expression and Impact on Cytoskeleton.

Camila Scagnetti, Hugo Yébenes, Silvia Requena, Noa B Martín-Cófreces

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Camila ScagnettiServicio de Inmunología, Instituto Investigación Sanitaria Princesa (IIS Princesa), Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Madrid, Spain.
Hugo YébenesFacultad de Ciencias de la Salud, Universidad Francisco de Vitoria, Pozuelo de Alarcón, Spain.
Silvia RequenaServicio de Inmunología, Instituto Investigación Sanitaria Princesa (IIS Princesa), Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Madrid, Spain.
Noa B Martín-CófrecesImmunology Service, Instituto de Investigación Sanitaria del Hospital Universitario La Princesa (IIS Princesa), Madrid, Spain. noa.martin@salud.madrid.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chaperones are proteins whose function is to intervene in the correct folding of newly synthesized polypeptides in the ribosome, thus providing their native conformation. CCT belongs to the Hsp60 family of chaperonins and is specifically a Type II subgroup. Here, we describe methods for determining and manipulating the CCT protein and RNA levels, as well as CCT distribution in cells, using complementary biochemical and imaging approaches. Protocols are provided for samples from primary human cells and established cell lines, including electrophoretic separation and immunoblotting. In parallel, procedures for immunofluorescence staining and microscopy are outlined, with emphasis on fixation, permeabilization, and antibody optimization. Critical parameters, appropriate controls, and troubleshooting considerations are discussed to facilitate robust and reproducible detection of CCT across different cellular systems.

Indexed as

Chaperonin Containing TCP-1CytoskeletonBlotting, WesternFluorescent Antibody TechniqueHumansJurkat CellsMicroscopy, FluorescenceRNA, Small InterferingChaperonin Containing TCP-1RNA, Small InterferingCCTCD4+ T lymphocytesChaperonineFluorescence microscopyImmunofluorescenceJurkatsiRNAWestern blot

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.